Form D · Biotechnology
IN8BIO, INC.
New York, NY · CIK 0001740279
Offering snapshot reported Dec 30, 2025 · SEC filing
- Reported sold
- $20.1M Offering amount: $40.2M
- Investors reported
- 17 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 22, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 30, 2025 | Initial | $20,119,049 | No comparison | 17 | SEC filing |
| Oct 15, 2024 | Initial | $12,379,983 | No comparison | 73 | SEC filing |
| Dec 28, 2023 | Initial | $14,425,013 | No comparison | 20 | SEC filing |
| Sep 4, 2020 | Amendment | $34,980,581 | $26,168,425vs Sep 20, 2018 | 33 | SEC filing |
| Sep 20, 2018 | Amendment | $8,812,156 | $4,054,626vs May 22, 2018 | 25 | SEC filing |
| May 22, 2018 | Initial | $4,757,530 | No comparison | 13 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $1.21M
- Finders' fees
- $0
- Form D file number
- 021-568472
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| H.C. Wainwright & Co., LLC | 375 |
Source: Form D, filed Dec 30, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Melissa Beelen | Executive |
| Peter Brandt | Director |
| Thomas Cirrito | Director |
| Corinne Epperly | Director |
| Emily R. Fairbairn | Director |
| Trishna Goswami | Executive |
| Jeremy Graff | Director |
| Luba Greenwood | Director |
| William Ho | Director, Executive |
| Lawrence Lamb | Executive |
| Larry Lamb | Executive |
| Patrick Mc Call | Executive |
| Kate Rochlin | Executive |
| Alan S. Roemer | Director |
| Travis Whitfill | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
Empire State Building 350 5 Th Avenue, Suite 5330
New York, NY, 10118
New York, NY, 10118